Medicaid advocates say critics use loaded terms to gain edge in Congressional debate

FHS
March 7, 2025
11:41 am

In Washington’s debate over enacting steep funding cuts to Medicaid, words are a central battleground.

FDA rejects Checkpoint Therapeutics’ PD-L1 drug cosibelimab over manufacturing issues

Checkpoint Therapeutics’ anti-PD-L1 antibody has been turned down by the FDA due to manufacturing issues, sending its share price down 45% premarket on Monday. The

December 19, 2023

Gut microbiota could affect the responsiveness and efficacy of cancer treatment

A vast number of microbes colonizes the human body to form an ecological community known as the microbiota. Microbiota are made up of bacteria, viruses,

August 11, 2023

Nasal decolonization decreases pediatric MRSA rates by 50%

Facing persistent cases of hospital-onset Methicillin-resistant Staphylococcus aureus (MRSA) during the pandemic, the infection prevention and control (IPC) team at Children’s Hospital New Orleans developed

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.